Page 235 - 2020_01-Haematologica-web

Neutrophils and cancer-associated thrombosis
Haemost. 2012;10(1):136-144.
21. Fuchs TA, Brill A, Wagner DD. Neutrophil
extracellular trap (NET) impact on deep vein thrombosis. Arterioscler Thromb Vasc Biol. 2012;32(8):1777-1783.
22. Noubouossie DF, Reeves BN, Strahl BD, Key NS. Neutrophils: back in the thrombosis spotlight. Blood. 2019;133(23):2529-2541.
23. Longstaff C, Varju I, Sotonyi P, et al. Mechanical stability and fibrinolytic resist- ance of clots containing fibrin, DNA, and histones. J Biol Chem. 2013;288(10):6946- 6956.
24. Mangold A, Alias S, Scherz T, et al. Coronary neutrophil extracellular trap bur- den and deoxyribonuclease activity in ST- elevation acute coronary syndrome are pre- dictors of ST-segment resolution and infarct size. Circ Res. 2015;116(7):1182-1192.
25. Jimenez-Alcazar M, Rangaswamy C, Panda R, et al. Host DNases prevent vascular occlu- sion by neutrophil extracellular traps. Science. 2017;358(6367):1202-1206.
26. von Bruhl ML, Stark K, Steinhart A, et al. Monocytes, neutrophils, and platelets coop- erate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med. 2012;209(4):819-835.
27. Meng H, Yalavarthi S, Kanthi Y, et al. In vivo tole of neutrophil extracellular traps in antiphospholipid antibody-mediated venous thrombosis. Arthritis Rheumatol. 2017;69(3):655-667.
28. El-Sayed OM, Dewyer NA, Luke CE, et al. Intact Toll-like receptor 9 signaling in neu- trophils modulates normal thrombogenesis in mice. J Vasc Surg. 2016;64(5):1450- 1458.e1.
29. Kenny EF, Herzig A, Kruger R, et al. Diverse stimuli engage different neutrophil extracel- lular trap pathways. Elife. 2017;6.
30. Li P, Li M, Lindberg MR, Kennett MJ, Xiong N, Wang Y. PAD4 is essential for antibacter- ial innate immunity mediated by neutrophil extracellular traps. J Exp Med. 2010;207(9): 1853-1862.
31. Stadler SC, Vincent CT, Fedorov VD, et al.
Dysregulation of PAD4-mediated citrullina- tion of nuclear GSK3beta activates TGF-beta signaling and induces epithelial-to-mes- enchymal transition in breast cancer cells. Proc Natl Acad Sci U S A. 2013;110(29): 11851-11856.
32. Wang Y, Li M, Stadler S, et al. Histone hyper- citrullination mediates chromatin deconden- sation and neutrophil extracellular trap for- mation. J Cell Biol. 2009;184(2):205-213.
33. Martinod K, Demers M, Fuchs TA, et al. Neutrophil histone modification by peptidy- larginine deiminase 4 is critical for deep vein thrombosis in mice. Proc Natl Acad Sci U S A. 2013;110(21):8674-8679.
34. Mauracher LM, Posch F, Martinod K, et al. Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, pre- dicts the risk of venous thromboembolism in cancer patients. J Thromb Haemost. 2018;16(3):508-518.
40. Noubouossie DF, Whelihan MF, Yu YB, et al. In vitro activation of coagulation by human neutrophil DNA and histone proteins but not neutrophil extracellular traps. Blood. 2017;129(8):1021-1029.
41. Thalin C, Daleskog M, Goransson SP, et al. Validation of an enzyme-linked immunosor- bent assay for the quantification of citrulli- nated histone H3 as a marker for neutrophil extracellular traps in human plasma. Immunol Res. 2017;65(3):706-712.
42. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New York, NY, USA: Taylor & Francis, 1993.
43. Nikolova N, Chai SH, Ivanova SD, Kolev K, Tenekedjiev K. Bootstrap Kuiper testing of the identity of 1D continuous distributions using fuzzy samples. International Journal of Computational Intelligence Systems. 2015; 8:63-75.
44. Wolberg AS. Thrombin generation and fib- rin clot structure. Blood Rev. 2007;21(3):131-
35. Oklu R, Sheth RA, Wong KHK, Jahromi AH,
Albadawi H. Neutrophil extracellular traps 142.
are increased in cancer patients but does not associate with venous thrombosis. Cardiovasc Diagn Ther. 2017;7(Suppl 3):S140-S149.
36. DuPre SA, Redelman D, Hunter KW Jr. The mouse mammary carcinoma 4T1: character- ization of the cellular landscape of primary tumours and metastatic tumour foci. Int J Exp Pathol. 2007;88(5):351-360.
37. Demers M, Krause DS, Schatzberg D, et al. Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis. Proc Natl Acad Sci U S A. 2012;109(32):13076-13081.
38. Leal AC, Mizurini DM, Gomes T, et al. Tumor-derived exosomes induce the forma- tion of neutrophil extracellular traps: impli- cations for the establishment of cancer-asso- ciated thrombosis. Sci Rep. 2017;7(1):6438.
39. Sommeijer DW, van Oerle R, Reitsma PH, et al. Analysis of blood coagulation in mice: pre-analytical conditions and evaluation of a home-made assay for thrombin-antithrom- bin complexes. Thromb J. 2005;3:12.
45. von Vietinghoff S, Ley K. Homeostatic regu- lation of blood neutrophil counts. J Immunol. 2008;181(8):5183-5188.
46. Demers M, Wong SL, Martinod K, et al. Priming of neutrophils toward NETosis pro- motes tumor growth. Oncoimmunology. 2016;5(5):e1134073.
47. Cedervall J, Zhang Y, Huang H, et al. Neutrophil extracellular traps accumulate in peripheral blood vessels and compromise organ function in tumor-bearing animals. Cancer Res. 2015;75(13): 2653-2662.
48. Schwarzenbach H, Hoon DS, Pantel K. Cell- free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011;11(6):426-437.
49. Swystun LL, Mukherjee S, Liaw PC. Breast cancer chemotherapy induces the release of cell-free DNA, a novel procoagulant stimulus. J Thromb Haemost. 2011;9(11):2313-2321.
50. Wang Y, Luo L, Braun OO, et al. Neutrophil extracellular trap-microparticle complexes enhance thrombin generation via the intrin- sic pathway of coagulation in mice. Sci Rep. 2018;8(1):4020.
haematologica | 2020; 105(1)
225